- Monedas 16 933
- Exchanges 1 268
- Capitalización $3 475 931 565 386
- 24H Vol $156 795 408 714
- Dominio BTC 59.14% ETH 9.05%
Metformin (met) Gráfico en Vivo
| Rango | Nombre | Premios | Evolución (24h) | Suministro total | En circulación | |
|---|---|---|---|---|---|---|
| 7064 |
MET
Metformin
MET
| $ 0.00 | -2.72% | 999 870 229 | 999 870 229 | AI Insight |
Metformin (met)
Our team of three experienced medical doctors, with a strong track record of publications in high-impact SCI and SCI-Expanded journals, is embarking on an ambitious research project to investigate the longevity benefits of metformin. Metformin, widely recognized for its efficacy in managing type 2 diabetes, has drawn growing interest for its potential to influence aging and chronic disease pathways. Preclinical and clinical studies suggest that metformin may play a pivotal role in modulating mechanisms associated with aging, opening new avenues for research in longevity science.
Pares Disponibles
| Rango | Par | Nombre | Volumen (24h) | |
|---|---|---|---|---|
| 1 | 7W9GX1WBAYS6KNTD5OZDNNDS887YCBO4YSCJ66DUPUMP / SO11111111111111111111111111111111111111112 | Raydium | $ 2 509.17 | ¡Explora! |